Celltrion, Inc. et al. v. Genentech, Inc. > Summary
Court Case Number IPR2017-00959
Filing Date Feb 21, 2017
Institution Decision Date -
Decision Date Sep 11, 2017
Court Patent Trial and Appeal Board
Status Terminated
Administrative JudgesErica A. Franklin
Judge Writing the Final DecisionErica A. Franklin
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
Petitioner
Patent Owner
Petitioner Attorneys
7Celltrion
Attorney Name: Cynthia Lambert Hardman
Goodwin Procter LLP
Genentech, Inc
Attorney Name: Owen K. Allen
Wilmer Cutler Pickering Hale and Dorr
Genentech, Inc
Attorney Name: David L. Cavanaugh
Wilmer Cutler Pickering Hale and Dorr
Celltrion
Attorney Name: Robert Vaughan Cerwinski
Goodwin Procter LLP
Celltrion
Attorney Name: Elaine H. Blais
Goodwin Procter LLP
Celltrion
Attorney Name: Robert J. Gunther Jr.
Wilmer Cutler Pickering Hale and Dorr
Celltrion
Attorney Name: Robert Charles Frederick Leonard
Imperial College London
Patent Owner Attorneys
2Genentech, Inc
Attorney Name: Adam R. Brausa
Morrison & Foerster
Genentech, Inc
Attorney Name: Daralyn J. Durie
Morrison & Foerster
Related Patents
Doc No | Title | Issue date |
---|---|---|
08591897 | Anti-ERBB2 antibody adjuvant therapy | Nov 26, 2013 |